Webinar – Future-proof your drug development investment with robust IP search strategies

Join Managing IP and CAS for a webinar at 5pm BST (12pm ET, 6pm CEST) on July 24 to learn how a strong intellectual property search strategy can ensure your pharmaceutical substance succeeds where others fail

A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money.

How do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable.

In this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including:

Essential novelty searches for pharmaceutical substances;
Tips for advanced IP search strategies and how they help to protect your research investment; and
The importance and hallmarks of trustworthy IP tools and partners.

Topics

Anne Marie Clark

Senior patent searcher CAS

Anne Marie is a senior scientist with CAS IP Services who specialises in sequence searching, biotechnology, formulations, organic chemistry, pharmaceuticals, small molecules, landscaping, and competitive benchmarking. She previously held intellectual property information and management roles at Long Eaton, Bausch & Lomb, and Pfizer.

Anne Marie holds a doctorate in biophysical chemistry from the University of Louisville and is a member of the Patent Information Users Group, the Licensing Executives Society, Women in Bio, the Association for Research in Vision and Ophthalmology, and Ophthalmic Women Leaders.

Heidi Berven

Partner Honigman

Heidi is a seasoned attorney with more than 10 years of experience. As patent counsel for large and small companies, she honed her skills in drafting and prosecuting chemistry and pharmaceutical patent applications and in providing intellectual property (IP) support for negotiations ranging from single-compound licensing transactions to whole-company acquisitions.

Her practice routinely includes patent preparation and prosecution, life cycle management of global patent portfolios, competitor intelligence, IP support for licensing negotiations, freedom-to-operate and patentability reviews, Orange Book listings for approved pharmaceutical products, and patent term adjustment maximisation by action before the USPTO and federal courts.